Source: European Medicines Agency (EU) Revision Year: 2019 Publisher: Chiesi Farmaceutici S.p.A., Via Palermo, 26/A, 43122 Parma, Italy
Quinsair 240 mg nebuliser solution.
| Pharmaceutical Form |
|---|
|
Nebuliser solution. Clear, pale yellow solution. |
Each ml of nebuliser solution contains levofloxacin hemihydrate equivalent to 100 mg of levofloxacin.
Each ampoule contains 240 mg of levofloxacin.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Levofloxacin |
Levofloxacin is a synthetic antibacterial agent of the fluoroquinolone class. As a fluoroquinolone antibacterial agent, levofloxacin acts on the DNA – DNA-gyrase complex and topoisomerase IV. |
| List of Excipients |
|---|
|
Magnesium chloride hexahydrate |
Ampoule: 3 ml, Low density polyethylene ampoule.
Sachet: Sealed foil laminate sachet containing 4 ampoules.
Inner box: 56 (14 sachets of 4) ampoules.
Outer box: Quinsair is supplied as a 28-day pack. This comprises an inner carton box containing 56 ampoules and a Package Leaflet. The outer carton box also contains one Zirela Nebuliser Handset packaged in its own carton box with the Manufacturer’s Instruction for Use.
Chiesi Farmaceutici S.p.A., Via Palermo, 26/A, 43122 Parma, Italy
EU/1/14/973/001
Date of first authorisation: 26/03/2015
| Drug | Countries | |
|---|---|---|
| QUINSAIR | Austria, Canada, Estonia, Spain, Finland, Croatia, Ireland, Italy, Lithuania, Netherlands, Poland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
